MWA
GOSS icon

MFA Wealth Advisors’s Gossamer Bio GOSS Stock Holding History

MFA Wealth Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,872
Closed -$1.85K – 196
2024
Q3 		$1.85K Hold
1,872
– – ﹤0.01% 437
2024
Q2 		$1.69K Buy
+1,872
New +$1.4K ﹤0.01% 453

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

MFA Wealth Advisors's GOSS Position: Q4 2024 in Review

MFA Wealth Advisors sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 1,872 shares — an estimated $1.85K sold.

MFA Wealth Advisors first reported a position in GOSS in Q2 2024 and held it in 2 quarters. The position peaked at $1.85K in Q3 2024. 105 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • MFA Wealth Advisors reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • MFA Wealth Advisors sold 1,872 Gossamer Bio shares in Q4 2024, an estimated $1.85K.
  • MFA Wealth Advisors first reported a position in Gossamer Bio in Q2 2024 and held it in 2 quarters.
  • MFA Wealth Advisors's Gossamer Bio position peaked at $1.85K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on MFA Wealth Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.